Alan J.  Levy net worth and biography

Alan Levy Biography and Net Worth

Director of Intuitive Surgical

Alan J. Levy, Ph.D., has been a member of our Board of Directors since February 2000 and has served as the independent lead director from April 2013 to April 2018. Dr. Levy was the Founder, Chairman, and Chief Executive Officer of Chrono Therapeutics, a privately held digital medicine company, from February 2014 to February 2018.

From 2012 to 2017, he was a Senior Advisor at Frazier Healthcare Ventures, and also a Venture Partner from 2007 to 2012. Dr. Levy previously was the Chief Executive Officer at Incline Therapeutics, Inc., Northstar Neuroscience, and Heartstream, Inc.

Dr. Levy currently serves as a member of the Board of Directors of several privately held companies and not-for-profit organizations.

Dr. Levy earned a B.S. in Chemistry from the City University of New York and a Ph.D. in Organic Chemistry from Purdue University.

What is Alan J. Levy's net worth?

The estimated net worth of Alan J. Levy is at least $10.54 million as of April 23rd, 2024. Dr. Levy owns 25,319 shares of Intuitive Surgical stock worth more than $10,536,249 as of July 18th. This net worth estimate does not reflect any other assets that Dr. Levy may own. Learn More about Alan J. Levy's net worth.

How do I contact Alan J. Levy?

The corporate mailing address for Dr. Levy and other Intuitive Surgical executives is 1020 KIFER ROAD, SUNNYVALE CA, 94086. Intuitive Surgical can also be reached via phone at (408) 523-2100 and via email at [email protected]. Learn More on Alan J. Levy's contact information.

Has Alan J. Levy been buying or selling shares of Intuitive Surgical?

Alan J. Levy has not been actively trading shares of Intuitive Surgical during the last ninety days. Most recently, Alan J. Levy sold 2,000 shares of the business's stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $370.70, for a transaction totalling $741,400.00. Following the completion of the sale, the director now directly owns 25,319 shares of the company's stock, valued at $9,385,753.30. Learn More on Alan J. Levy's trading history.

Who are Intuitive Surgical's active insiders?

Intuitive Surgical's insider roster includes Craig Barratt (Director), Mark Brosius (SVP), Myriam Curet (EVP), Myriam Curet (EVP), Robert DeSantis (EVP), Gary Guthart (CEO), Amal Johnson (Director), Amy Ladd (Director), Keith Leonard (Director), Alan Levy (Director), Marshall Mohr (CFO), Kara Reiter (SVP), David Rosa (EVP), Mark Rubash (Director), Jamie Samath (SVP), and Fredrik Widman (VP). Learn More on Intuitive Surgical's active insiders.

Are insiders buying or selling shares of Intuitive Surgical?

During the last year, insiders at the medical equipment provider sold shares 43 times. They sold a total of 381,391 shares worth more than $137,626,118.18. The most recent insider tranaction occured on June, 12th when Director Craig H. Barratt sold 1,400 shares worth more than $589,484.00. Insiders at Intuitive Surgical own 0.9% of the company. Learn More about insider trades at Intuitive Surgical.

Information on this page was last updated on 6/12/2024.

Alan J. Levy Insider Trading History at Intuitive Surgical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/23/2024Sell2,000$370.70$741,400.0025,319View SEC Filing Icon  
1/26/2024Sell2,000$370.20$740,400.0025,319View SEC Filing Icon  
11/14/2023Sell2,000$290.00$580,000.0025,319View SEC Filing Icon  
8/7/2023Sell2,000$310.00$620,000.0025,319View SEC Filing Icon  
10/22/2021Sell7,500$339.64$2,547,300.00View SEC Filing Icon  
4/23/2021Sell2,500$856.79$2,141,975.008,094View SEC Filing Icon  
1/26/2021Sell2,500$754.48$1,886,200.0010,339View SEC Filing Icon  
5/26/2020Sell1,950$575.00$1,121,250.009,789View SEC Filing Icon  
1/29/2020Sell1,950$575.00$1,121,250.009,527View SEC Filing Icon  
10/24/2017Sell2,997$371.35$1,112,935.95View SEC Filing Icon  
4/24/2017Sell1,386$813.15$1,127,025.902,598View SEC Filing Icon  
8/4/2016Sell3,188$694.11$2,212,822.685,401View SEC Filing Icon  
4/26/2016Sell542$631.72$342,392.242,213View SEC Filing Icon  
3/10/2016Sell5,000$569.14$2,845,700.007,213View SEC Filing Icon  
6/9/2015Sell417$495.41$206,585.97View SEC Filing Icon  
See Full Table

Alan J. Levy Buying and Selling Activity at Intuitive Surgical

This chart shows Alan J Levy's buying and selling at Intuitive Surgical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Intuitive Surgical Company Overview

Intuitive Surgical logo
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Read More

Today's Range

Now: $416.14
Low: $413.82
High: $427.33

50 Day Range

MA: $420.68
Low: $380.88
High: $445.11

2 Week Range

Now: $416.14
Low: $254.85
High: $449.00


3,851,133 shs

Average Volume

1,529,288 shs

Market Capitalization

$147.60 billion

P/E Ratio


Dividend Yield